Third generation oral contraceptives

BMJ

Volumn 312, Issue 7030, 1996, Pages 576-

  Ketting, Evert ^a  

^a Netherlands Institute of Social Sexological Research   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT; DESOGESTREL; ETHINYLESTRADIOL; GESTODENE; NORGESTIMATE;

CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; FEMALE; HEALTH; HUMAN; LETTER; RISK FACTOR; WOMEN'S HEALTH; ACNE; AGE; DATA BASE; DRUG MARKETING; DRUG NOMENCLATURE; DRUG SAFETY; FAMILY PLANNING; HEADACHE; HEALTH EDUCATION; INDUCED ABORTION; MEDICAL DECISION MAKING; METHODOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC OPINION; RISK; SMOKING HABIT; THROMBOEMBOLISM; WEIGHT GAIN;

CARDIOVASCULAR DISEASES; CONTRACEPTIVES, ORAL, SYNTHETIC; FEMALE; HUMANS; RISK FACTORS; WOMEN'S HEALTH; WORLD HEALTH;

EID: 0030059921     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.312.7030.576     Document Type: Letter

References (4)

1. Committee on Safety of Medicines. Combined oral contraceptives and thromboembolism. London: CSM, 1995.
2. Royal College of General Practitioners' Oral Contraception Study. Mortality among oral-contraceptive users. Lancet 1977; 2: 727–731.
3. Ketting E. De teloorgang van “de pil.” Zeist: Netherlands Institute of Social Sexological Research, 1981.
4. World Health Organisation. Abortion, a tabulation of available data on the frequency and mortality of unsafe abortion. 2nd ed. Geneva: WHO, 1994.